LexaGene: Automated, Rapid Pathogen Detection

LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-ne …

LexaGene Holdings pathogen detection

MiQLab automated pathogen detection system

LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected. Further, the system offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.

More on MiQLab

LexaGene’s MiQLab™ system aims to transform pathogen detection in multi-billion-dollar-markets.

MiQLab brings reference laboratory quality data to the point-of-need where samples are collected—to quickly detect multiple pathogens at once with sensitivity and specificity—and return results in ~1 hour. MiQLab is an automated, multiplexing PCR-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.

For more information on LexaGene Holdings, Inc., (TSX.V: LXG, OTCQB: LXXGF) please fill out the form below.

You might also like

Eminent Gold: Why Is Nevada Still One of the Most Competitive Gold Exploration Regions?
Metals & Mining
May 26, 2026

Eminent Gold: Why Is Nevada Still One of the Most Competitive Gold Exploration Regions?

This is some text inside of a div block.
Canada’s Critical Minerals Push Could Drive the Next Wave of Energy Investment: Lance Mortlock, EY Canada
May 25, 2026

Canada’s Critical Minerals Push Could Drive the Next Wave of Energy Investment: Lance Mortlock, EY Canada

This is some text inside of a div block.
Canada’s Defense Spending Surge Could Reshape Industry Growth: EY Canada
May 25, 2026

Canada’s Defense Spending Surge Could Reshape Industry Growth: Jeff Hamilton, EY Canada

This is some text inside of a div block.
Subscribe and receive the investor Info